Completed PHASE4 INTERVENTIONAL 2-arm NCT00685607

Study to Determine the Best Way to Measure How Quickly the Drug Can Give Relief From Sudden Diarrhea

A Placebo-Controlled, Double-Blind, Randomized Pilot Study to Evaluate the Appropriateness of Multiple Endpoints in Measuring the Onset of Clinical Efficacy of Loperamide-Simethicone Caplets in the Treatment of Acute Non-specific Diarrhea

Sponsor: Johnson & Johnson Consumer and Personal Products Worldwide

Conditions Diarrhea

Interventions loperamide-simethicone matching placebo

Updated 6 times since 2017 Last updated: Oct 4, 2011 Started: Oct 31, 2008 Primary completion: Oct 31, 2008 Completion: Oct 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00685607, this PHASE4 trial focuses on Diarrhea and remains completed. Sponsored by Johnson & Johnson Consumer and Personal Products Worldwide, it has been updated 6 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Oct 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Johnson & Johnson Consumer and Personal Products Worldwide

Data source: Johnson & Johnson Consumer and Personal Products Worldwide

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guadalajara, Mexico